RecallDepth
Class II Ongoing

Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.

This recall is currently active, issued November 12, 2025. It was issued by Teva Pharmaceuticals Usa, Inc.

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
October 13, 2025
Posted
November 12, 2025
Recall Number
D-0151-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4680 cartons
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Subpotent drug; Clavulanate Potassium component

Distribution

Distributed in three (3) States: MS, OH, CA.

Lot / Code Info

Lot # 100062316, Exp Date: 01/2026

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls